Find Faculty
Zhenyu Yue, PhD
img_Zhenyu Yue
PROFESSOR | Neurology
PROFESSOR | Neuroscience
212 824 9144 to 9153 Lab
email
Research Topics
Alzheimer's Disease, Apoptosis/Cell Death, Autophagy, Axonal Growth and Degeneration, Human Genetics and Genetic Disorders, Knockout Mice, Lysosomes/endosome, Molecular Biology, Neuro-degeneration/protection, Parkinson's Disease, Protein Degradation, Protein Kinases, Protein Trafficking & Sorting, Schizophrenia, Synapses
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
147
Publications

Selected Publications

Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Insup Choi, Minghui Wang, Seungyeul Yoo, Peng Xu, Steven P. Seegobin, Xianting Li, Xian Han, Qian Wang, Junmin Peng, Bin Zhang, Zhenyu Yue. Nature Cell Biology

Gut bacterial profiles in Parkinson's disease: A systematic review. Zhe Li, Hongfeng Liang, Yingyu Hu, Lin Lu, Chunye Zheng, Yuzhen Fan, Bin Wu, Tao Zou, Xiaodong Luo, Xinchun Zhang, Yan Zeng, Ziyan Liu, Zhicheng Zhou, Zhenyu Yue, Yi Ren, Zhuo Li, Qiaozhen Su, Pingyi Xu. CNS Neuroscience and Therapeutics

Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy. Insup Choi, George R. Heaton, You Kyung Lee, Zhenyu Yue. Science advances

View All Publications

Hess Center For Science & Med Floor 9 Room 9-106 (office); 9-201 Lab

1470 Madison Ave

New York, NY 10029

212 824 9144 to 9153 Lab

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Yue during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Company Founder:

  • YUNIPEUTICS INC

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • YUNIPEUTICS INC

Royalty Payments:

  • Genentech, Inc.
  • Pfizer Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.